Enlivex Therapeutics Ltd. (ENLV)
NASDAQ·Healthcare·Biotechnology
$2.20
-1.79%
Mkt Cap $28.19M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+581.8%
Consensus $15.00 vs current $2.20
NASDAQ·Healthcare·Biotechnology
$2.20
-1.79%
Mkt Cap $28.19M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+581.8%
Consensus $15.00 vs current $2.20